<DOC>
	<DOC>NCT01714973</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of ACCS in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ACCS treated burns with those treated with saline placebo controls.</brief_summary>
	<brief_title>Study of Amnion-derived Cellular Cytokine Solution (ACCS) Versus Saline in Treating Skin Irritation From Radiation</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>A signed IRB approved Informed Consent; Women 18 80 years of age; Biopsyproven diagnosis of breast cancer with the tumor surgically removed. Whole breast radiation with or without ipsilateral axilla radiation therapy recommended by her radiation oncologist. If a woman is of childbearing potential, she and her partner must use an effective form of birth control. Willing to participate in the clinical study and comply with the requirements of the trial. Abnormal liver or kidney function studies being greater than 2x the upper limit of normal. Patients on hemodialysis Psychiatric condition or substance abuse which in the Investigator's opinion may pose a threat to patient compliance; History of noncompliance with treatment or clinical visit attendance. Participation in an investigational trial within 30 days of study entry. Women who are pregnant or lactating</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>